HCV, hepatitis C virus

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
A K Burroughs, R Groszmann, J Bosch, N Grace, G Garcia-Tsao, D Patch, J C Garcia-Pagan, L Dagher

Gut Mar 2002, 50 (3) 425-427; DOI: 10.1136/gut.50.3.425
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
M R Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, S M Tavangar, L Moezi, S Payabvash, A Karoon, H Hoseininik, D A Mann, K P Moore, A R Mani, A R Dehpour

Gut Nov 2006, 55 (11) 1606-1616; DOI: 10.1136/gut.2005.076778
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment
K Weissenborn, J C Ennen, M Bokemeyer, B Ahl, U Wurster, H Tillmann, C Trebst, H Hecker, G Berding

Gut Nov 2006, 55 (11) 1624-1630; DOI: 10.1136/gut.2005.080267
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy
M Sherman, E M Yoshida, M Deschenes, M Krajden, V G Bain, K Peltekian, F Anderson, K Kaita, S Simonyi, R Balshaw, S S Lee

Gut Nov 2006, 55 (11) 1631-1638; DOI: 10.1136/gut.2005.083113
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Nai-Jen Hou, Li-Po Lee, Ming-Yen Hsieh, Chang-Fu Chiu, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang

Gut Apr 2007, 56 (4) 553-559; DOI: 10.1136/gut.2006.102558
A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence
J-C Duclos-Vallée, M Sebagh, K Rifai, C Johanet, E Ballot, C Guettier, V Karam, M Hurtova, C Feray, M Reynes, H Bismuth, D Samuel

Gut Jun 2003, 52 (6) 893-897; DOI: 10.1136/gut.52.6.893
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy
T Asselah, D Vidaud, A Doloy, N Boyer, M Martinot, M Vidaud, D Valla, P Marcellin

Gut Jun 2003, 52 (6) 900-902; DOI: 10.1136/gut.52.6.900
The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease
L Frelin, E D Brenndörfer, G Ahlén, M Weiland, C Hultgren, M Alheim, H Glaumann, B Rozell, D R Milich, J G Bode, M Sällberg

Gut Oct 2006, 55 (10) 1475-1483; DOI: 10.1136/gut.2005.085050
Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients
G Harcourt, E Gomperts, S Donfield, P Klenerman

Gut Oct 2006, 55 (10) 1484-1487; DOI: 10.1136/gut.2005.083758
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
M Wali, R F Harrison, P J Gow, D Mutimer

Gut Aug 2002, 51 (2) 248-252; DOI: 10.1136/gut.51.2.248

Main menu

HCV, hepatitis C virus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

HCV, hepatitis C virus

Pages